Fundraising rounds for health startups are taking longer to close and investors are doing more due diligence, said Ulili Onovakpuri, managing partner of Kapor Capital, during a Monday panel at the MedCity INVEST conference in Chicago.
Which capital funding options fit your healthcare or life science business?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Learn from our expert panel as they discuss the challenges and opportunities of value-based contracting.
Learn from payers focused on health tech, medical device investors and others on what investment trends to watch for this year.
Skip Kelly, a managing director at J.P. Morgan, provides a broad overview of how the healthcare investment landscape is shaping up in the midst of a historic pandemic, as part of MedCity's 2021 INVEST conference.
With so many new entrants hoping to cash in on the success of digital health, it is more important than ever to look for a venture capital firm that has the right relationships and expertise.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Healthcare investing reached record new highs in 2018, hitting more than $30 billion across all sectors, according to numbers from Pitchbook.
River Cities Capital Funds, a growth equity firm investing in high-potential healthcare and IT companies, is pleased to announce the final closing of its fifth fund. Fund V has reached a $200 million hard cap. Dan Fleming, Managing Director of River Cities, says, “With a $200M fund, River Cities is a significant player pursuing investments in […]